Use of a polarizing field to modify the efficacy of a bioactive agent
US6749596B2 · kind B2 · utility
2Cited by
23References
27Claims
0Family size
Inventor
Key dates
| Filing date | Jul 15, 2002 |
| Grant date | Jun 15, 2004 |
| Priority date | — |
| Expiry date | Jul 15, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N2/02
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A bioactive agent is administered to a patient, and the efficacy of the bioactive agent is modified by exposing the patient to a polarizing field. The bioactive agent may be a chemotherapeutic agent administered to a patient with cancer, and the polarizing field may be an electric field and/or a magnetic field. The direction and/or strength of the polarizing field may be changed during treatment to promote the opportunity for enhanced therapeutic interaction between the bioactive agent and the field.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.